[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Autacoids and Related Drugs Market Report 2017

August 2017 | 102 pages | ID: U423AAF8DF9EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Autacoids and Related Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Autacoids and Related Drugs in these regions, from 2012 to 2022 (forecast).
United States Autacoids and Related Drugs market competition by top manufacturers/players, with Autacoids and Related Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bedford Laboratories
  • Bristol-Myers Squibb
  • APP Pharma
  • Abbott Laboratories
  • Sanofi
  • Chattem
  • Xanodyne
  • AstraZeneca
  • Hospira
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Polypeptides
  • Decarboxylated Amino Acids
  • Eicosanoids
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Autacoids and Related Drugs for each application, including
  • Allergies
  • Inflammation
  • Gastric Acid Secretion
  • Neuroendocrine Regulation
  • Chronic Pain
  • Cardiovascular Diseases
  • Gastrointestinal Diseases
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Autacoids and Related Drugs Market Report 2017

1 AUTACOIDS AND RELATED DRUGS OVERVIEW

1.1 Product Overview and Scope of Autacoids and Related Drugs
1.2 Classification of Autacoids and Related Drugs by Product Category
  1.2.1 United States Autacoids and Related Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Autacoids and Related Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Polypeptides
  1.2.4 Decarboxylated Amino Acids
  1.2.5 Eicosanoids
1.3 United States Autacoids and Related Drugs Market by Application/End Users
  1.3.1 United States Autacoids and Related Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Allergies
  1.3.3 Inflammation
  1.3.4 Gastric Acid Secretion
  1.3.5 Neuroendocrine Regulation
  1.3.6 Chronic Pain
  1.3.7 Cardiovascular Diseases
  1.3.8 Gastrointestinal Diseases
1.4 United States Autacoids and Related Drugs Market by Region
  1.4.1 United States Autacoids and Related Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Autacoids and Related Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Autacoids and Related Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Autacoids and Related Drugs Status and Prospect (2012-2022)
  1.4.5 New England Autacoids and Related Drugs Status and Prospect (2012-2022)
  1.4.6 The South Autacoids and Related Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Autacoids and Related Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Autacoids and Related Drugs (2012-2022)
  1.5.1 United States Autacoids and Related Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Autacoids and Related Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES AUTACOIDS AND RELATED DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Autacoids and Related Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Autacoids and Related Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Autacoids and Related Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Autacoids and Related Drugs Market Competitive Situation and Trends
  2.4.1 United States Autacoids and Related Drugs Market Concentration Rate
  2.4.2 United States Autacoids and Related Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Autacoids and Related Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AUTACOIDS AND RELATED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Autacoids and Related Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Autacoids and Related Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Autacoids and Related Drugs Price by Region (2012-2017)

4 UNITED STATES AUTACOIDS AND RELATED DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Autacoids and Related Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Autacoids and Related Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Autacoids and Related Drugs Price by Type (2012-2017)
4.4 United States Autacoids and Related Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AUTACOIDS AND RELATED DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Autacoids and Related Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Autacoids and Related Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AUTACOIDS AND RELATED DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bedford Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bedford Laboratories Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
  6.2.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 APP Pharma
  6.3.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 APP Pharma Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Chattem
  6.6.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Chattem Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Xanodyne
  6.7.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Xanodyne Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AstraZeneca
  6.8.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AstraZeneca Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Hospira
  6.9.2 Autacoids and Related Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hospira Autacoids and Related Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 AUTACOIDS AND RELATED DRUGS MANUFACTURING COST ANALYSIS

7.1 Autacoids and Related Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Autacoids and Related Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Autacoids and Related Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Autacoids and Related Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AUTACOIDS AND RELATED DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Autacoids and Related Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Autacoids and Related Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Autacoids and Related Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Autacoids and Related Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Autacoids and Related Drugs
Figure United States Autacoids and Related Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Autacoids and Related Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Polypeptides Product Picture
Figure Decarboxylated Amino Acids Product Picture
Figure Eicosanoids Product Picture
Figure United States Autacoids and Related Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Autacoids and Related Drugs by Application in 2016
Figure Allergies Examples
Table Key Downstream Customer in Allergies
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Gastric Acid Secretion Examples
Table Key Downstream Customer in Gastric Acid Secretion
Figure Neuroendocrine Regulation Examples
Table Key Downstream Customer in Neuroendocrine Regulation
Figure Chronic Pain Examples
Table Key Downstream Customer in Chronic Pain
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Gastrointestinal Diseases Examples
Table Key Downstream Customer in Gastrointestinal Diseases
Figure United States Autacoids and Related Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Autacoids and Related Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Autacoids and Related Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Autacoids and Related Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Autacoids and Related Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Autacoids and Related Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Autacoids and Related Drugs Sales Share by Players/Suppliers
Figure 2017 United States Autacoids and Related Drugs Sales Share by Players/Suppliers
Figure United States Autacoids and Related Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Autacoids and Related Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Autacoids and Related Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Autacoids and Related Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Autacoids and Related Drugs Revenue Share by Players/Suppliers
Table United States Market Autacoids and Related Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Autacoids and Related Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Autacoids and Related Drugs Market Share of Top 3 Players/Suppliers
Figure United States Autacoids and Related Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Autacoids and Related Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Autacoids and Related Drugs Product Category
Table United States Autacoids and Related Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Autacoids and Related Drugs Sales Share by Region (2012-2017)
Figure United States Autacoids and Related Drugs Sales Share by Region (2012-2017)
Figure United States Autacoids and Related Drugs Sales Market Share by Region in 2016
Table United States Autacoids and Related Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Autacoids and Related Drugs Revenue Share by Region (2012-2017)
Figure United States Autacoids and Related Drugs Revenue Market Share by Region (2012-2017)
Figure United States Autacoids and Related Drugs Revenue Market Share by Region in 2016
Table United States Autacoids and Related Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Autacoids and Related Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Autacoids and Related Drugs Sales Share by Type (2012-2017)
Figure United States Autacoids and Related Drugs Sales Share by Type (2012-2017)
Figure United States Autacoids and Related Drugs Sales Market Share by Type in 2016
Table United States Autacoids and Related Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Autacoids and Related Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Autacoids and Related Drugs by Type (2012-2017)
Figure Revenue Market Share of Autacoids and Related Drugs by Type in 2016
Table United States Autacoids and Related Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Autacoids and Related Drugs Sales Growth Rate by Type (2012-2017)
Table United States Autacoids and Related Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Autacoids and Related Drugs Sales Market Share by Application (2012-2017)
Figure United States Autacoids and Related Drugs Sales Market Share by Application (2012-2017)
Figure United States Autacoids and Related Drugs Sales Market Share by Application in 2016
Table United States Autacoids and Related Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Autacoids and Related Drugs Sales Growth Rate by Application (2012-2017)
Table Bedford Laboratories Basic Information List
Table Bedford Laboratories Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bedford Laboratories Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Bedford Laboratories Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Bedford Laboratories Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table APP Pharma Basic Information List
Table APP Pharma Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure APP Pharma Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure APP Pharma Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure APP Pharma Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Chattem Basic Information List
Table Chattem Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chattem Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Chattem Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Chattem Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Xanodyne Basic Information List
Table Xanodyne Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Xanodyne Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Xanodyne Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Xanodyne Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Hospira Basic Information List
Table Hospira Autacoids and Related Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hospira Autacoids and Related Drugs Sales Growth Rate (2012-2017)
Figure Hospira Autacoids and Related Drugs Sales Market Share in United States (2012-2017)
Figure Hospira Autacoids and Related Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Autacoids and Related Drugs
Figure Manufacturing Process Analysis of Autacoids and Related Drugs
Figure Autacoids and Related Drugs Industrial Chain Analysis
Table Raw Materials Sources of Autacoids and Related Drugs Major Players/Suppliers in 2016
Table Major Buyers of Autacoids and Related Drugs
Table Distributors/Traders List
Figure United States Autacoids and Related Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Autacoids and Related Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Autacoids and Related Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Autacoids and Related Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Autacoids and Related Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Autacoids and Related Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories